Clinical Trial

Phase I Trial of pH Resections of GBM at VA

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
Glioblastoma is an infiltrating tumor that is difficult to visualize in surgery and on standard images. A special pH (acid-base) related magnetic resonance imaging (MRI) has been developed to better see infiltrating tumor. In this safety study, the investigators will carry out increased levels of pH based resections of infiltrating tumor to assess the tolerability in VA populations.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-10-15; most recent amendment 2026-02-10.
Trial Details
NCT Number NCT07218367
Lead Sponsor VA Office of Research and Development
Collaborators: University of California, Los Angeles
Conditions Glioblastoma
Enrollment 12 participants
Start Date 2026-07-01
Primary Completion 2031-07-01 (estimated)
Study Completion 2031-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-13